Evoke Pharma Inc

San Diego, CA · Founded 2007 · CIK 0001403708 · Biotech · Acquired

Oral small molecule therapeutics for diabetic gastroparesis and gastrointestinal disorders

evokepharma.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$6.0M
1 Form D · Jun 2010
195 months since last filing
Contracts
—
No federal contracts on record
Patents
30
7 granted · 23 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$6,000,001
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1865Tetragenetics, Inc.—$7.1M
1866Regenerative Medical Solutions Inc—$7.0M
1867Angarus Therapeutics, Inc.—$6.9M
1868Evoke Pharma Inc—$6.0M
1869Kiniksa Pharmaceuticals—$5.9M
1870Jennerex, Inc.—$5.4M
1871AKTTYVA THERAPEUTICS, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 7 related persons
  • Todd BradyDirector
  • Matt D'OnofrioExecutive Officer
  • Cam GarnerDirector
  • Scott GlennDirector
  • David GonyerDirector · Executive Officer
  • Malcolm HillDirector
  • Kenneth WidderDirector

Patents

USPTO · 7 granted of 30

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.